EXUMA Biotechnology
Manufacturing · United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.exumabiotech.comRevenue
$7.7 MillionIndustry
About EXUMA Biotechnology
EXUMA Biotechnology Org Chart
Is EXUMA Biotechnology your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at EXUMA Biotechnology
Funding: Get notified immidiatlly once EXUMA Biotechnology has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if EXUMA Biotechnology had a recent Job posting/layoffs
EXUMA Biotechnology, which may be a good buyer, showed buying intent in Masked Content Topic
Check if EXUMA Biotechnology has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on EXUMA Biotechnology recently announced quarterly report
Check out if EXUMA Biotechnology is spiking on competitors!
Product Launch: Get notified when EXUMA Biotechnology launches new products
Recommended Actions
Reach out to Masked Content who joined EXUMA Biotechnology as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
EXUMA Biotechnology is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
EXUMA Biotechnology is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about EXUMA Biotechnology.
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding EXUMA Biotechnology
EXUMA Biotech is a clinical-stage biotechnology company developing gene vector delivery solutions and products for cell and gene therapy. Founded in 2015, the company discovers and develops therapies for cancer and autoimmune diseases. Its technology portfolio includes the GCAR platform for in vivo CAR-T therapy and the rPOC SC platform for chemoth... Read More

